Insulet Announces FDA Clearance of Omnipod GO, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

25.04.2023 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the FDA clearance of its latest innovation, Omnipod GO, an insulin delivery device ...

Related Keywords

United States ,Massachusetts ,Jim Hollingshead ,Insulet Corporation ,Business Wire ,Chief Executive ,Omnipod Insulin Management System ,Insulin Delivery System ,Insulet Stock ,Insulet ,